my understanding is that the delivery is not related to the drug, so a deal to deliver a drug would be relatively easy to get some runs on board with. Drugs in current use already have their toxicity worked out, and if FPP delivery is say 10 times better we can expect 10 times less drug to have the same effect, or we may be able to increase the drug level without the side effects, thus making the drug more likely to work.. So there would not be barriers to this kind of delivery, and the side effects would markedly reduce. These kinds of deals, to work these existing compounds up and make sure it is all effective, are our short term revenue hopes. And we also have Blood brain barrier patents now so.... more possibilities.
PYC Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)